通用显示器 OLED 深 沪
已收盘 02-06 16:00:00 美东时间
121.11
+8.060
+7.13%
华盛通- 最 高121.715
- 今 开113.78
- 成交量 119.02万股
- 最 低 113.78
- 昨 收 113.05
- 总市值 57.58亿
- 52周最高 162.49
- 市盈率 静 26.05
- 换手率 2.50%
- 52周最低 102.35
- 委 比 -39.85%
- 总股本 4754.22万
- 历史最高 255.97
- 量 比 1.18
- 振 幅 7.02%
- 历史最低 13.39
- 每 手 1
- 风险率 14.42%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
Universal Display Corporation to Release Fourth Quarter and Full Year Financial Results
Universal Display Corporation to Release Fourth Quarter and Full Year Financial Results Universal Display Corporation will release its fourth quarter and full year 2025 financial results on Thursday, February 19, 2026, after market close. The results will be available on the Company's website at htt
01-27 05:15
Oppenheimer’s best small and mid-cap ideas for 2026
Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year. Analysts said that, absent the traditional warning signs that have historically preceded market down...
01-07 00:59
Universal Display Signs Agreements With Tianma To Provide UniversalPHOLED Phosphorescent OLED Materials, Technologies to Tianma
Universal Display Corporation (UDC) (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced the signing of long-term OLED material supply
01-06 05:18
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
Needham Reiterates Buy on Universal Display, Maintains $150 Price Target
Needham analyst James Ricchiuti reiterates Universal Display (NASDAQ:OLED) with a Buy and maintains $150 price target.
2025-12-22 19:25
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
Universal Display Corporation declares $0.45 dividend
Universal Display Corporation (OLED) declared $0.45/share quarterly dividend, in line with previous. Forward yield 1.33% Payable Dec. 31; for shareholders of record Dec. 17; ex-div Dec. 17. See OLED D...
2025-11-07 07:08
